Feedback / Questions
otlertuzumab (TRU 016) - Emergent Biosolutions
Emergent Biosolutions: Credit Suisse Antibody Day
(Emergent Biosolutions)
-
May 10, 2013 -
"Progression Free Survival Intent to Treat by Response"
P1 data
•
Hematological Malignancies • Non-Hodgkin's Lymphoma
http://cc.talkpoint.com/cred001/051013a_am/?entity=1_J4SGRB0
May 10, 2013
SHARE THIS
Print
Email
More sharing
Reddit
StumbleUpon
Delicious
.